Observational studyPloS one2024

Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immune-mediated inflammatory diseases-an observational study.

Graeme Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.